Dr Nenad Miljković, President-elect of the European Association of Hospital Pharmacists (EAHP), outlines the critical role of cold chain management in maintaining the efficacy and safety of vaccines.
Open Access Government discusses the prevalence of neglected tropical diseases, including barriers to awareness and the need to scale up effective interventions.
Wales is set to introduce a vaccination program aimed at protecting vulnerable populations from a common but potentially severe respiratory infection known as Respiratory Syncytial Virus (RSV).
Researchers from the Wellcome Sanger Institute, University College London (UCL), and Imperial College London have revealed insights into why some people remain unscathed despite exposure to SARS-CoV-2, the virus responsible for COVID-19.
An HIV vaccine candidate developed at the Duke Human Vaccine Institute has demonstrated the ability to trigger low levels of a rare type of neutralising antibodies (bnAbs) in a small group of participants.
Vaccinations are one of the most important medical developments that will have benefits on a person's health, potentially for their whole life. CoolMed explains...
Heidi J Larson, along with contributors from the Vaccine Confidence Project, discuss the complex factors influencing decision-making around vaccines and what can be done to improve public trust.
The need for public health officials to be able to model the spread of an infectious disease has never been more apparent than in the early days of the SARS-CoV-2 pandemic.
From the 11th of March 2020 to the 5th of May 2023, the world experienced a global health emergency. In response, Policy Recommendations will be presented at the EU Parliament in an effort to prioritise care for high-risk COVID-19 patients in the EU.
The UK Health Security Agency (UKHSA) has secured a groundbreaking UK-based vaccine deal, strengthening the nation's readiness for potential influenzas pandemics.
Tuberculosis is the second most infectious deadly disease after COVID-19, so why has it been met with political inertia? Vinny Wooding, Senior Parliamentary Advocacy Officer at RESULTS UK, discusses the burden of TB and the rapid action needed to address this global threat.
New polio vaccines: Two groundbreaking oral polio vaccines (nOPVs) have been created by scientists at UCSF and the UK's National Institute of Biological Standards and Control (NIBSC).
Harrison Thomas, the Content Marketing Executive at CoolMed, discusses what the healthcare industry should consider when purchasing a medical fridge or freezer.
